Index IndexTemplate TemplateConstraints Constraints

DPM Map for eba_tF_19.00.e

AddressLabelMetricsData TypePeriod Typeeba_dim:APLeba_dim:BASeba_dim:CPSeba_dim:CPZeba_dim:FBSeba_dim:MCBeba_dim:MCGeba_dim:MCYeba_dim:PFSeba_dim:PUR
r0.170eba_a2.root/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstantN/Aeba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x223N/AN/A
r0.175eba_a2.root/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstantN/Aeba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x223eba_IM:x16N/A
180.170DEBT INSTRUMENTS VALUED AT COST OR AT AMORTISED COST/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x223N/AN/A
180.175DEBT INSTRUMENTS VALUED AT COST OR AT AMORTISED COST/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x223eba_IM:x16N/A
005.170Cash balances at central banks and other demand deposits/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x12eba_BA:x6eba_CT:x583N/Aeba_IM:x12eba_MC:x824eba_MC:x409eba_MC:x469N/AN/A
005.175Cash balances at central banks and other demand deposits/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x12eba_BA:x6eba_CT:x583N/Aeba_IM:x12eba_MC:x824eba_MC:x409eba_MC:x469eba_IM:x16N/A
010.170Debt securities/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60N/AN/A
010.175Debt securities/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60eba_IM:x16N/A
020.170Central banks/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x10N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60N/AN/A
020.175Central banks/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x10N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60eba_IM:x16N/A
030.170General governments/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x1N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60N/AN/A
030.175General governments/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x1N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60eba_IM:x16N/A
040.170Credit institutions/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x12N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60N/AN/A
040.175Credit institutions/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x12N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60eba_IM:x16N/A
050.170Other financial corporations/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x18N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60N/AN/A
050.175Other financial corporations/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x18N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60eba_IM:x16N/A
060.170Non-financial corporations/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x20N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60N/AN/A
060.175Non-financial corporations/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x20N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60eba_IM:x16N/A
070.170Loans and advances/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x103eba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
070.175Loans and advances/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x103eba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
080.170Central banks/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x103eba_BA:x6eba_CT:x10N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
080.175Central banks/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x103eba_BA:x6eba_CT:x10N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
090.170General governments/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x103eba_BA:x6eba_CT:x1N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
090.175General governments/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x103eba_BA:x6eba_CT:x1N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
100.170Credit institutions/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x103eba_BA:x6eba_CT:x12N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
100.175Credit institutions/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x103eba_BA:x6eba_CT:x12N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
110.170Other financial corporations/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x18N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
110.175Other financial corporations/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x18N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
120.170Non-financial corporations/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x20N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
120.175Non-financial corporations/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x20N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
130.170Of which: Small and Medium-sized Enterprises/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x20eba_CT:x23eba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
130.175Of which: Small and Medium-sized Enterprises/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x20eba_CT:x23eba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
140.170Of which: Loans collateralised by commercial immovable property/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x20N/Aeba_IM:x12N/Aeba_MC:x918eba_MC:x469N/AN/A
140.175Of which: Loans collateralised by commercial immovable property/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x20N/Aeba_IM:x12N/Aeba_MC:x918eba_MC:x469eba_IM:x16N/A
150.170Households/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x5N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
150.175Households/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x5N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
160.170Of which: Loans collateralised by residential immovable property/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x5N/Aeba_IM:x12N/Aeba_MC:x919eba_MC:x469N/AN/A
160.175Of which: Loans collateralised by residential immovable property/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x5N/Aeba_IM:x12N/Aeba_MC:x919eba_MC:x469eba_IM:x16N/A
170.170Of which: Credit for consumption/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x5N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/Aeba_PU:x1
170.175Of which: Credit for consumption/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_CT:x5N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16eba_PU:x1
201.170DEBT INSTRUMENTS AT FAIR VALUE THROUGH OTHER COMPREHENSIVE INCOME OR THROUGH EQUITY SUBJECT TO IMPAIRMENT/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x223N/AN/A
201.175DEBT INSTRUMENTS AT FAIR VALUE THROUGH OTHER COMPREHENSIVE INCOME OR THROUGH EQUITY SUBJECT TO IMPAIRMENT/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x223eba_IM:x16N/A
181.170Debt securities/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60N/AN/A
181.175Debt securities/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60eba_IM:x16N/A
182.170Central banks/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x10N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60N/AN/A
182.175Central banks/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x10N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60eba_IM:x16N/A
183.170General governments/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x1N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60N/AN/A
183.175General governments/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x1N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60eba_IM:x16N/A
184.170Credit institutions/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x12N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60N/AN/A
184.175Credit institutions/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x12N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60eba_IM:x16N/A
185.170Other financial corporations/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x18N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60N/AN/A
185.175Other financial corporations/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x18N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60eba_IM:x16N/A
186.170Non-financial corporations/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x20N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60N/AN/A
186.175Non-financial corporations/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x20N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60eba_IM:x16N/A
191.170Loans and advances/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
191.175Loans and advances/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
192.170Central banks/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x10N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
192.175Central banks/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x10N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
193.170General governments/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x1N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
193.175General governments/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x1N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
194.170Credit institutions/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x12N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
194.175Credit institutions/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x12N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
195.170Other financial corporations/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x18N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
195.175Other financial corporations/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x18N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
196.170Non-financial corporations/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x20N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
196.175Non-financial corporations/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x20N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
900.170Of which: Small and Medium-sized Enterprises/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x20eba_CT:x23eba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
900.175Of which: Small and Medium-sized Enterprises/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x20eba_CT:x23eba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
903.170Of which: Loans collateralised by commercial immovable property/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x20N/Aeba_IM:x12N/Aeba_MC:x918eba_MC:x469N/AN/A
903.175Of which: Loans collateralised by commercial immovable property/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x20N/Aeba_IM:x12N/Aeba_MC:x918eba_MC:x469eba_IM:x16N/A
197.170Households/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x5N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
197.175Households/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x5N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
910.170Of which: Loans collateralised by residential immovable property/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x5N/Aeba_IM:x12N/Aeba_MC:x919eba_MC:x469N/AN/A
910.175Of which: Loans collateralised by residential immovable property/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x5N/Aeba_IM:x12N/Aeba_MC:x919eba_MC:x469eba_IM:x16N/A
913.170Of which: Credit for consumption/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x5N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/Aeba_PU:x1
913.175Of which: Credit for consumption/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_CT:x5N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16eba_PU:x1
231.170DEBT INSTRUMENTS AT STRICT LOCOM, OR FAIR VALUE THROUGH PROFIT OR LOSS OR THROUGH EQUITY NOT SUBJECT TO IMPAIRMENT/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x223N/AN/A
231.175DEBT INSTRUMENTS AT STRICT LOCOM, OR FAIR VALUE THROUGH PROFIT OR LOSS OR THROUGH EQUITY NOT SUBJECT TO IMPAIRMENT/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x223eba_IM:x16N/A
211.170Debt securities/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60N/AN/A
211.175Debt securities/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60eba_IM:x16N/A
212.170Central banks/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x10N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60N/AN/A
212.175Central banks/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x10N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60eba_IM:x16N/A
213.170General governments/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x1N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60N/AN/A
213.175General governments/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x1N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60eba_IM:x16N/A
214.170Credit institutions/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x12N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60N/AN/A
214.175Credit institutions/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x12N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60eba_IM:x16N/A
215.170Other financial corporations/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x18N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60N/AN/A
215.175Other financial corporations/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x18N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60eba_IM:x16N/A
216.170Non-financial corporations/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x20N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60N/AN/A
216.175Non-financial corporations/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x20N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x60eba_IM:x16N/A
221.170Loans and advances/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
221.175Loans and advances/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
222.170Central banks/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x10N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
222.175Central banks/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x10N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
223.170General governments/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x1N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
223.175General governments/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x1N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
224.170Credit institutions/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x12N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
224.175Credit institutions/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x12N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
225.170Other financial corporations/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x18N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
225.175Other financial corporations/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x18N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
226.170Non-financial corporations/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x20N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
226.175Non-financial corporations/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x20N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
920.170Of which: Small and Medium-sized Enterprises/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x20eba_CT:x23eba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
920.175Of which: Small and Medium-sized Enterprises/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x20eba_CT:x23eba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
923.170Of which: Loans collateralised by commercial immovable property/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x20N/Aeba_IM:x12N/Aeba_MC:x918eba_MC:x469N/AN/A
923.175Of which: Loans collateralised by commercial immovable property/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x20N/Aeba_IM:x12N/Aeba_MC:x918eba_MC:x469eba_IM:x16N/A
227.170Households/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x5N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/AN/A
227.175Households/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x5N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16N/A
930.170Of which: Loans collateralised by residential immovable property/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x5N/Aeba_IM:x12N/Aeba_MC:x919eba_MC:x469N/AN/A
930.175Of which: Loans collateralised by residential immovable property/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x5N/Aeba_IM:x12N/Aeba_MC:x919eba_MC:x469eba_IM:x16N/A
933.170Of which: Credit for consumption/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x5N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469N/Aeba_PU:x1
933.175Of which: Credit for consumption/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_CT:x5N/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x469eba_IM:x16eba_PU:x1
330.170DEBT INSTRUMENTS OTHER THAN HELD FOR TRADING OR TRADING/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x77eba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x223N/AN/A
330.175DEBT INSTRUMENTS OTHER THAN HELD FOR TRADING OR TRADING/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x77eba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x223eba_IM:x16N/A
335.170DEBT INSTRUMENTS HELD FOR SALE/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x13eba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x223N/AN/A
335.175DEBT INSTRUMENTS HELD FOR SALE/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x13eba_BA:x6N/AN/Aeba_IM:x12N/Aeba_MC:x409eba_MC:x223eba_IM:x16N/A

Legal Notice: This demo website displays data, which is publicly available on the Internet. Copyright of all materials is owned by the corresponding data provider. Links to data providers are given for each taxonomy. Data is displayed without any change of lexical information, or identifiers. No part of this website should be considered normative information.

© 2021 by Skynet LLC